DLBDolby Laboratories exhibits strong fundamentals and positive thematic alignment, though current technical indicators suggest a neutral-to-cautious short-term outlook. It's a solid candidate for long-term growth portfolios.
Dolby's core technologies are integral to the evolving media and entertainment landscape, benefiting from trends in immersive audio/video and content delivery.
Dolby Laboratories demonstrates robust profitability, a healthy balance sheet, and consistent earnings growth, albeit with some fluctuations in revenue.
The stock is trading within a recent range, with mixed signals from short-term indicators. Key moving averages suggest a neutral trend, while some oscillators indicate potential overbought conditions.
| Factor | Score |
|---|---|
| Immersive Audio/Video | 85 |
| Content Delivery & Streaming | 70 |
| Cinema & Broadcast Technology | 65 |
| Emerging Technologies (SaaS) | 75 |
| Competitive Landscape | 70 |
| Factor | Score |
|---|---|
| Valuation | 65 |
| Profitability | 85 |
| Growth | 70 |
| Balance Sheet Health | 95 |
| Cash Flow | 80 |
| Dividends | 75 |
| Factor | Score |
|---|---|
| Trend Analysis | 45 |
| Momentum | 55 |
| Volume Confirmation | 70 |
| Support & Resistance | 70 |
| Short-term Oscillators | 40 |
Attractive Valuation Metrics
The Price-to-Earnings (P/E) ratio of 28.91 is lower than the industry average, and the Price-to-Sales (P/S) ratio of 7.1 indicates potential value for investors.
Consistent Earnings Surprises
Dolby Laboratories (DLB) has consistently exceeded EPS estimates in recent quarters, with positive surprises ranging from 5.79% to 41.4%, indicating strong operational execution.
Recent Underperformance
The stock has experienced negative performance over the last 6 months (-5.09%) and year-to-date (-1.07%), suggesting recent market headwinds or investor sentiment shifts.
High Quarterly P/E Ratio
The quarterly P/E ratios are significantly high (e.g., 121.9 in Q2 2024), indicating that current earnings may not fully justify the stock's price, potentially pointing to overvaluation.
May 2025
13
Ex-Dividend Date
May 2025
21
Next Dividend Date
August 2025
1
Next Earnings Date
H: $0.73
A: $0.71
L: $0.69
H: 315.35M
A: 305.23M
L: 295.14M
Dolby Laboratories, Inc. engages in the design and manufacture of audio, imaging, accessibility, and other hardware and software solutions primarily for application in the television, broadcast, and live entertainment industries in the United States and internationally. The company develops and licenses its audio technologies, such as AAC, HE-AAC, and extended HE-AAC, a digital audio codec solution; AVC, a digital video codec used in STBs, mobile devices, cameras, and broadcast television services and other products; and Dolby Atmos and Dolby Vision include encoding technologies that artists use to create more compelling and immersive audio and video experiences. Its audio technologies also include DD+, an advanced surround sound audio codec technology; Dolby AC-4, an audio codec that uses cutting edge compression; and HEVC, a next-generation digital video codec that compresses video. In addition, the company offers Dolby Cinemas, a premium large format cinemas that deliver a Dolby branded premium cinema offering with Dolby Vision, Dolby Atmos, and a Dolby theater design; Dolby.io, a next generation SaaS product of immersive, interactive, and social experiences with real-time engagement for live events, especially sports; and digital cinema servers, cinema processors, amplifiers, loudspeakers, and audio and imaging hardware and software products for the cinema, television, broadcast, communication, and entertainment industries. Further, it provides various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment. The company serves film studios, content creators, post-production facilities, and broadcasters. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California.
102.33 USD
The 39 analysts offering 1 year price forecasts for DLB have a max estimate of 112.00 and a min estimate of 95.00.